Urology Today.net

Site updated at Thursday, 12 May 2016

Common Urological Problems

Progression Free Survival

Mixed Results for New Tx in Adrenal Cancer

Patients with advanced adrenocortical carcinoma lived no longer when standard therapy was combined with three-agent chemotherapy, but had a significantly higher response rate and progression-free survival (PFS), results of a large multicenter study showed.

Overall survival improved by almost 3 months with etoposide-doxorubicin-cisplatin (EDP) chemotherapy plus mitotane when compared with mitotane plus streptozocin, but… Mixed Results for New Tx in Adrenal Cancer   

prostate cancers1 - prostate cancer foundation3 - dissolution agents1 - diabetes treatment1 - markers of prostate cancer1 - molecular markers1 - cancer therapy1 - tumor metabolism1 - laser light1 - clinical journal of the american society nephrology3 - sexual satisfaction1 - x-ray1 - adolescent overweight1 - dietary fat1 - pelvic irradiation1 - urinary tract3 - johnson & johnson1 - balkan nephritis1 - asn14 - uterine cancer2 - lab-made kidney1 - jevtana1 - circumcised men1 - percutaneous nephrolithotomy1 - mutation1 - cystolithotomy1 - prostate tissue1 - kidney patients3 - electromagnetic lithotripter1 - vomiting1 -